Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study-Reference-Cited by-同舟云学术

Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study

Published:2015-12-10 Issue:2 Volume:10 Page:377-385
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Assem M.,Elsabaawy M.,Abdelrashed M.,Elemam S.,Khodeer S.,Hamed W.,Abdelaziz A.,El-Azab G.

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-015-9688-z.pdf

Reference42 articles.

1. Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin for the prevention of spontaneous bacterial peritonitis. World J Gastroenterol 2012;18:1700–1702

2. Koulaouzidis A. Diagnosis of spontaneous bacterial peritonitis: an update on leucocyte esterase reagent strips. World J Gastroenterol 2011;17:1091–1094

3. Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011;17:1237–1248

4. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002;35:140–148

5. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010;26:17–25

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of rifaximin in liver diseases;Biomedicine & Pharmacotherapy;2024-09

2. Chinese consensus on the management of liver cirrhosis;Journal of Digestive Diseases;2024-06

3. Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis;European Journal of Gastroenterology & Hepatology;2024-05-27

4. Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota;Antibiotics;2023-09-22

5. Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?;Hepatology Communications;2023-08-31